Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment

American Journal of Neuroradiology

Volumn 27, Issue 7, 2006, Pages 1454-1458

  Giesel, Frederik Lars ^a,d   Hahn, H K ^b   Thomann, P A ^c   Widjaja, E ^d   Wignall, E ^d   Von Tengg Kobligk, H ^a   Pantel, J ^e   Griffiths, P D ^d   Peitgen, H O ^b   Schroder, J ^c   Essig, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FRAUNHOFER MEVIS   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; BRAIN ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; QUANTITATIVE DIAGNOSIS; RISK ASSESSMENT; TEMPORAL LOBE; VOLUMETRY;

AGED; ALZHEIMER DISEASE; ATROPHY; CEREBRAL VENTRICLES; COGNITION; COGNITION DISORDERS; HIPPOCAMPUS; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARAHIPPOCAMPAL GYRUS; TEMPORAL LOBE;

EID: 33747501457     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
2. Kazee AM, Eskin TA, Lapham LW, et al. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 1993;7:152-64
3. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-64
4. Seab JP, Jagust WJ, Wong ST, et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988;8:200-08
5. Kesslak JP, Nalcioglu U, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54
6. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-88
7. de Leon MJ, George AE, Golomb J, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18: 1-11
8. Nagy Z, Hindley NJ, Braak H, et al. The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 1999;10:115-20
9. Smith AD, Jobst KA. Use of structural imaging to study the progression of Alzheimer's disease. Br Med Bull 1996;52:575-86
10. Shen D, Moffat S, Resnick SM, et al. Measuring size and shape of the hippocampus in MR images using a deformable shape model. Neuroimage 2002;15: 422-34
11. Hogan RE, Mark KE, Wang L, et al. Mesial temporal sclerosis and temporal lobe epilepsy: MR imaging deformation-based segmentation of the hippocampus in five patients. Radiology 2000;216:291-97
12. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147-59
13. Hahn HK, Rexilius J, Schlüter M. Fast and robust quantification of parahippocampal atrophy via temporal horn index. In: Tolxdorff T, Braun J, Handels H, et al, eds. Bildverarbeitung für die Medizin 2004: Algorithmen-Systeme-Anwendungen. Berlin: Springer-Verlag; 2004:371-75. Available at: http://ftp. informatik.rwth-aachen.de/Publications/CEUR-WS/Vol-116/p371.pdf
14. Schroder J, Kratz B, Pantel J, et al. Prevalence of mild cognitive impairment in an elderly community sample. J Neurol Transm Suppl 1998;54:51-59
15. Reisberg B, Ferris SH, de Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139: 1136-39
16. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994;6:63-68
17. Hahn HK, Millar WS, Klinghammer O, et al. A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroimaging. Methods Inf Med 2004;43:376-82
18. Hahn HK, Peitgen HO. IWT-Interactive watershed transform: a hierarchical method for efficient interactive and automated segmentation of multidimensional gray-scale images. Proc SPIE 2003;5032:643-53.
19. Parnetti L, Lowenthal DT, Presciutti O, et al. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc 1996;44:133-38
20. Juottonen K, Laakso MP, Partanen K, et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 1999;20:139-44
21. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-94
22. Thacker NA, Varma AR, Bathgate D, et al. Dementing disorders: volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings-feasibility study. Radiology 2002;224:278-85
23. Jack CR Jr, Petersen RC, Xu Y, et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998;51:993-99
24. Frisoni GB, Beltramello A, Weiss C, et al. Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol 1996;17:913-23
25. Dahlbeck JW, McCluney KW, Yeakley JW, et al. The interuncal distance: a new MR measurement for the hippocampal atrophy of Alzheimer disease. AJNR Am J Neuroradiol 1991;12:931-32
26. Soininen H, Puranen M, Riekkinen PJ. Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry 1982;45: 50-54
27. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-72
28. Erkinjuntti T, Lee DH, Gao F, et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993;50:305-10
29. Frisoni GB, Geroldi C, Beltramello A, et al. Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol 2002;23: 35-47
30. Jack CR Jr, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology 2003;60: 253-60
31. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19
32. Petrella JR, Coleman RE, Doraiswamy PM. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003;226:315-36
33. Pantel J, Kratz B, Essig M, et al. Parahippocampal volume deficits in subjects with aging-associated cognitive decline. Am J Psychiatry 2003;160:379-82
34. Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44: 1660-68
35. Laakso MP, Partanen K, Lehtovirta M, et al. MRI of amygdala fails to diagnose early Alzheimer's disease. Neuroreport 1995;6:2414-18
36. Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1998;19:23-31